CCTG

MA.32

NCT01286233

MA32

Study of Biomarkers Associated With Fatigue in Patients With Early-Stage Breast Cancer Treated With Metformin or Placebo on NCIC-CTG-MA.32

Status:

Closed to Accrual

26459-200.png

III

Phase

Line of Therapy.png

n/a

Line of Therapy

Disease Stage.png

Early Cancer

Disease Stage

Target.png

Biomarker(s)

N/A

Investigational

Product

Metformin

Antihyperglycemic agent

Treatment Arms

o Group 1: Metformin

o Group 2: Placebo